Skaff Michael C — SEC Form 4 filings

SEC reporting owner CIK 2074003. 2 Form 4 filings on record with FilingPulse; latest filed 2026-07-15.

Transaction summary — filings shown

Covers all 2 filings on record, filed 2026-04-02 to 2026-07-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Vivos Therapeutics, Inc. (VVOS)10% owner22 legs · 1,353,625 sh · $1,813,8586

Form 4 filings — Skaff Michael C

FiledFormIssuerReported transactionsSource
2026-07-154Vivos Therapeutics, Inc. (VVOS)Purchase (P): 859,166 (derivative) @ $0.58 · Purchase (P): 1,890,164 (derivative) @ $0.58 · Purchase (P): 2,749,330 (derivative) @ $0.58EDGAR
2026-04-024Vivos Therapeutics, Inc. (VVOS)
jointly with V-Co Investors 3 LLC
Purchase (P): 1,044,777 @ $1.34 · Purchase (P): 308,848 @ $1.34 · Purchase (P): 429,957 (derivative) @ $1.34 · Purchase (P): 1,783,582 (derivative) @ $1.34 · Purchase (P): 1,783,582 (derivative) @ $1.34EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2074003 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →